Status:
COMPLETED
Cognitive Impairment Following Sedation for Colonoscopy With Propofol, Midazolam and Fentanyl Combinations
Lead Sponsor:
Melbourne Health
Conditions:
Cognitive Impairment
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Our hypothesis is that adding midazolam and/or fentanyl to propofol sedation for elective outpatient colonoscopy increases cognitive impairment at hospital discharge without improving intraoperative c...
Detailed Description
A great variety of drug combinations are administered to patients having elective outpatient colonoscopy. In addition, as patients are going home, some may have residual cognitive deficits that making...
Eligibility Criteria
Inclusion
- Aged 18 years or older presenting for elective outpatient colonoscopy following full bowel preparation
Exclusion
- No cognitive impairment
- Adequate English language comprehension
- Not combined with other procedures
Key Trial Info
Start Date :
February 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2008
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00446420
Start Date
February 1 2007
End Date
February 1 2008
Last Update
May 30 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Melbourne Hospital
Parkville, Victoria, Australia, 3050